CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting ...

Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet ...

Bacteria Striking Back Bacterial infections are much less deadly than they used to be before the introduction of antibiotics. “Before we had antibiotics, infections like scarlet fever could even lead ...

The world’s first norovirus vaccine is set to be trialled by the NHS in a bid to ease the strain on already stretched ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do ...

The global mRNA synthesis and manufacturing market is projected to grow from USD 624.4 million in 2024 to USD 738.3 million ...

18 analysts have expressed a variety of opinions on Moderna MRNA over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of ...

On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna (NASDAQ:MRNA). This decision ...

On the sell side, ARK divested a large portion of its stake in Moderna Inc (NASDAQ:MRNA), selling 160,994 shares across ARKK and ARKG ETFs for a total of $9,476,106. This trade marks a significant ...

On the sell side, ARK divested a large portion of its stake in Moderna Inc (NASDAQ:MRNA), selling 160,994 shares across ARKK and ARKG ETFs for a total of $9,476,106. This trade marks a significant ...

Moderna’s stock has been under scrutiny following its recent announcement of a revised financial plan and updates to its mRNA-based pipeline. CEO Stéphane Bancel highlighted the company’s ...

Of course, a lot of upside could potentially be left on the table if MRNA shares really soar, which is why looking at the trailing twelve month trading history for Moderna Inc, as well as studying ...